Φορτώνει......
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome
BACKGROUND: Hepatorenal syndrome is a potentially reversible renal failure associated with severe liver disease. The disease is relatively common among people with decompensated cirrhosis. Terlipressin is a drug that increases the blood flow to the kidneys by constricting blood vessels. The previous...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cochrane Database Syst Rev |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley & Sons, Ltd
2017
|
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481608/ https://ncbi.nlm.nih.gov/pubmed/29943803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005162.pub4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|